A promising treatment for Covid-19 comes from a most unusual source - an anti-depressant treatment. Is the evidence compelling? What should we believe?
Many clinician researchers are attempting to "repurpose" old treatments for COVID-19. How shold we evaluate purported positive findings in a small, but rigorous, clinical trial?
You may have heard, “Always do subgroup analysis, but never believe them.” Don't believe this.